JP2015524788A5 - - Google Patents

Download PDF

Info

Publication number
JP2015524788A5
JP2015524788A5 JP2015501980A JP2015501980A JP2015524788A5 JP 2015524788 A5 JP2015524788 A5 JP 2015524788A5 JP 2015501980 A JP2015501980 A JP 2015501980A JP 2015501980 A JP2015501980 A JP 2015501980A JP 2015524788 A5 JP2015524788 A5 JP 2015524788A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
cells
apc
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015501980A
Other languages
English (en)
Japanese (ja)
Other versions
JP6259983B2 (ja
JP2015524788A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2013/004248 external-priority patent/WO2014010231A1/en
Publication of JP2015524788A publication Critical patent/JP2015524788A/ja
Publication of JP2015524788A5 publication Critical patent/JP2015524788A5/ja
Application granted granted Critical
Publication of JP6259983B2 publication Critical patent/JP6259983B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015501980A 2012-07-10 2013-07-09 Th1細胞のKIF20Aエピトープペプチドおよびこれを含有するワクチン Expired - Fee Related JP6259983B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261669999P 2012-07-10 2012-07-10
US61/669,999 2012-07-10
PCT/JP2013/004248 WO2014010231A1 (en) 2012-07-10 2013-07-09 Kif20a epitope peptides for th1 cells and vaccines containing the same

Publications (3)

Publication Number Publication Date
JP2015524788A JP2015524788A (ja) 2015-08-27
JP2015524788A5 true JP2015524788A5 (enExample) 2016-06-02
JP6259983B2 JP6259983B2 (ja) 2018-01-17

Family

ID=49915712

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015501980A Expired - Fee Related JP6259983B2 (ja) 2012-07-10 2013-07-09 Th1細胞のKIF20Aエピトープペプチドおよびこれを含有するワクチン

Country Status (5)

Country Link
US (3) US9561265B2 (enExample)
EP (1) EP2872530A4 (enExample)
JP (1) JP6259983B2 (enExample)
TW (4) TW201925220A (enExample)
WO (1) WO2014010231A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164826A2 (en) 2014-04-24 2015-10-29 Rhode Island Hospital ASPARTATE-β-HYDROXYLASE INDUCES EPITOPE-SPECIFIC T CELL RESPONSES IN TUMORS
HRP20210698T1 (hr) 2015-12-22 2021-09-17 Immatics Biotechnologies Gmbh Peptidi i kombinacija peptida za uporabu u imunoterapiji protiv karcinoma dojke i drugih karcinoma
GB201522667D0 (en) * 2015-12-22 2016-02-03 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers
TW201831502A (zh) * 2016-11-18 2018-09-01 日商腫瘤療法 科學股份有限公司 對於th1細胞的depdc1抗原決定位胜肽及包含其之疫苗
TW201831503A (zh) * 2016-11-18 2018-09-01 日商腫瘤療法 科學股份有限公司 對於th1細胞的mphosph1抗原決定位胜肽及包含其之疫苗
TWI787500B (zh) * 2018-04-23 2022-12-21 美商南特細胞公司 新抗原表位疫苗及免疫刺激組合物及方法
US11564980B2 (en) 2018-04-23 2023-01-31 Nantcell, Inc. Tumor treatment method with an individualized peptide vaccine

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
JP2000516090A (ja) 1996-07-26 2000-12-05 スローン―ケッタリング インスティチュート フォー キャンサー リサーチ 遺伝子的免疫化のための方法と試薬
AU749544B2 (en) 1998-06-25 2002-06-27 Dainippon Sumitomo Pharma Co., Ltd. Tumor antigen peptides originating in cyclophilin B
US7504490B1 (en) * 1998-10-16 2009-03-17 Oscient Pharmaceuticals Corporation Nucleic acid and amino acid sequences relating to Apergillus fumigatus for diagnostics and therapeutics
US6395527B1 (en) * 2000-08-17 2002-05-28 Cytokinetics, Inc. Motor proteins and methods for their use
US7125663B2 (en) * 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
US20040142325A1 (en) * 2001-09-14 2004-07-22 Liat Mintz Methods and systems for annotating biomolecular sequences
US20060143729A1 (en) * 2004-06-30 2006-06-29 Ceres, Inc. Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
US7998695B2 (en) 2005-02-10 2011-08-16 Oncotherapy Science, Inc. Method of diagnosing bladder cancer
EP2305811A1 (en) 2005-07-27 2011-04-06 Oncotherapy Science, Inc. Method of diagnosing smal cell lung cancer
EP1928227A4 (en) * 2005-08-30 2009-05-20 Monsanto Technology Llc TRANSGENIC PLANTS WITH IMPROVED AGRONOMIC CHARACTERISTICS
DK1987178T3 (en) * 2006-02-20 2015-04-20 Phylogica Ltd Process for the construction and screening of peptide structure libraries
EP2052088A2 (en) * 2006-08-02 2009-04-29 Genizon Biosciences Genemap of the human genes associated with psoriasis
WO2008102906A1 (en) 2007-02-20 2008-08-28 Oncotherapy Science, Inc. Hspc-hrpc transition genes
TWI494319B (zh) 2007-02-21 2015-08-01 Oncotherapy Science Inc 表現腫瘤相關抗原之癌症的胜肽疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
MX2011004176A (es) * 2008-10-22 2011-09-21 Oncotherapy Science Inc Peptido-epitope rab6kifl/kif20a y vacunas que contienen el mismo.
WO2011119484A1 (en) * 2010-03-23 2011-09-29 Iogenetics, Llc Bioinformatic processes for determination of peptide binding

Similar Documents

Publication Publication Date Title
JP2015529629A5 (enExample)
JP2014523406A5 (enExample)
JP2013511958A5 (enExample)
JP2013521789A5 (enExample)
JP2017538401A5 (enExample)
JP2017525336A5 (enExample)
HRP20141233T1 (hr) PEPTIDNA CJEPIVA DOBIVENA IZ EphA4
JP2018532382A5 (enExample)
JP2018536383A5 (enExample)
JP2019510465A5 (enExample)
JP2018511321A5 (enExample)
JP2016511221A5 (enExample)
JP2016525498A5 (enExample)
JP2015524652A5 (enExample)
HRP20192262T1 (hr) Nova imunoterapija protiv nekoliko tumora, kao što su rak pluća, uključujući mikrocelularni karcinom pluća (nsclc)
Welten et al. Memory CD 8 T cell inflation vs tissue‐resident memory T cells: Same patrollers, same controllers?
JP2012517799A5 (enExample)
PE20181897A1 (es) Inmunoterapia contra el melanoma y otros tipos de cancer
JP2019508044A5 (enExample)
JP2011524737A5 (enExample)
RU2012127358A (ru) Олигопептиды imp-3 и содержащие их вакцины
JP2014519311A5 (enExample)
JP2013523084A5 (enExample)
RU2015143164A (ru) Пептиды kntc2 и содержащие их вакцины
JP2012102105A5 (enExample)